Literature DB >> 9767878

[Transmission modes of hepatitis C virus].

M Karmochkine1, F Carrat, A J Valleron, G Raguin.   

Abstract

SITUATION IN FRANCE: The prevalence of hepatitis C virus (HCV) infection in the French population is estimated at 1%, a level similar to that in other western countries. USUAL CONTAMINATION ROUTES: Epidemiological studies, together with gene typing, have made it possible to distinguish transmission modes. A history of intravenous drug abuse or transfusion is found in 60 to 80% of all subjects infected by the HCV. Other documented modes of contamination include hemodialysis, organ transplantation, accidental occupational-related puncture and mother-infant transmission. OTHER ROUTES: Sexual or intra-familial nonsexual transmission is uncommon and related to the length of exposure and the stage of HCV infection in the "source" subjects. Cases of HCV transmission have been reported during medical procedures. Currently the mode of of transmission is unknown in 20 to 40% of the cases.

Entities:  

Mesh:

Year:  1998        PMID: 9767878

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Decline in HCV testing and compliance with guidelines in patients of Sentinelles general practitioners, 1996-2002.

Authors:  Véronique Massari; Cécile Viboud; Yves Dorléans; Antoine Flahault
Journal:  Eur J Epidemiol       Date:  2006-05-20       Impact factor: 8.082

2.  Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.

Authors:  Thomas Bourlet; Rachel Levy; Silvy Laporte; Stéphane Blachier; Laurence Bocket; Guy Cassuto; Lionel Chollet; Marianne Leruez-Ville; Anne Maertens; Fabienne Mousnier; Christophe Pasquier; Christopher Payan; Bertrand Pellegrin; Evelyne Schvoerer; Patricia Zavadzki; Jacques Chouteau; Gilles Duverlie; Jacques Izopet; Françoise Lunel-Fabiani; Jean-Michel Pawlotsky; Nerina Profizi; Christine Rouzioux; Françoise Stoll-Keller; Vincent Thibault; Pierre Wattré; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.